BTCY (Biotricity) Cyclically Adjusted Book per Share: $-1.17 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BTCY Biotricity Inc BTCY
20 GF Score
Price $0.09
GF Value $0.37
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Biotricity Cyclically Adjusted Book per Share?

Biotricity BTCY -13.29% 20 Cyclically Adjusted Book per Share is $-1.17 as of Jun. 2026. GuruFocus rates BTCY with a GF Score™ of 20/100 and a GF Value™ of $0.37 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Biotricity's adjusted book value per share for the three months ended in Jun. 2026 was $-1.870. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-1.17 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-03), Biotricity's current stock price is $0.09. Biotricity's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $-1.17. Biotricity's Cyclically Adjusted PB Ratio of today is .


Biotricity  (OTCPK:BTCY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Biotricity Cyclically Adjusted Book per Share Related Terms


Biotricity Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Biotricity's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotricity Cyclically Adjusted Book per Share Chart

Biotricity Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.02 -1.14

Biotricity Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.05 -1.09 -1.11 -1.14 -1.17

BTCY vs IVF, CSDX, ADMT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Biotricity's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotricity Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotricity's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biotricity's Cyclically Adjusted PB Ratio falls into.


BTCY
20GF Score
Biotricity Inc BTCY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotricity Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biotricity's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-1.87/333.9520*333.9520
=-1.870

Current CPI (Jun. 2026) = 333.9520.

Biotricity Quarterly Data

Book Value per Share CPI Adj_Book
201609 -0.576 241.428 -0.797
201612 -0.930 241.432 -1.286
201703 -0.967 243.801 -1.325
201706 -0.701 244.955 -0.956
201709 -0.019 246.819 -0.026
201712 0.370 246.524 0.501
201803 0.033 249.554 0.044
201806 -0.134 251.989 -0.178
201809 -0.113 252.439 -0.149
201812 -0.148 251.233 -0.197
201903 -0.302 254.202 -0.397
201906 -0.553 256.143 -0.721
201909 -0.814 256.759 -1.059
201912 -0.316 256.974 -0.411
202003 -0.495 258.115 -0.640
202006 -0.805 257.797 -1.043
202009 -1.194 260.280 -1.532
202012 -1.700 260.474 -2.180
202103 -1.051 264.877 -1.325
202106 -1.618 271.696 -1.989
202109 0.951 274.310 1.158
202112 0.280 278.802 0.335
202203 -0.251 287.504 -0.292
202206 -0.762 296.311 -0.859
202209 -1.228 296.808 -1.382
202212 -1.778 296.797 -2.001
202303 -2.267 301.836 -2.508
202306 -2.675 305.109 -2.928
202309 -3.034 307.789 -3.292
202312 -2.946 306.746 -3.207
202403 -3.307 312.332 -3.536
202406 -1.376 314.175 -1.463
202409 -1.354 315.301 -1.434
202412 -1.301 315.605 -1.377
202503 -1.220 319.799 -1.274
202506 -1.227 322.561 -1.270
202509 -1.240 324.800 -1.275
202512 -1.224 324.054 -1.261
202603 -1.206 330.213 -1.220
202606 -1.870 333.952 -1.870

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-1.17 mean?
Biotricity (BTCY) has a Cyclically Adjusted Book per Share of $-1.17 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Biotricity and its competitors.
Is Biotricity's Cyclically Adjusted Book per Share too high?
Biotricity's current Cyclically Adjusted Book per Share is $-1.17. Overall, Biotricity has a GF Score™ of 20/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biotricity's Cyclically Adjusted Book per Share compare to IVF and CSDX?
Biotricity's Cyclically Adjusted Book per Share of $-1.17 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Biotricity and its competitors. Biotricity's current Cyclically Adjusted Book per Share is $-1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotricity stock overvalued right now?
Based on GuruFocus' analysis, Biotricity (BTCY) is currently considered Possible Value Trap. The stock's GF Value™ is $0.37, compared to a current price of $0.09 — trading 75.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is $-1.17. Biotricity's overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Biotricity (BTCY), the current Cyclically Adjusted Book per Share is $-1.17 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biotricity (BTCY) Overvalued in 2026?

Based on GuruFocus' analysis, Biotricity stock appears to be undervalued. The current stock price of $0.09 is trading 75.7% below its estimated GF Value™ of $0.37. GuruFocus considers Biotricity to be Possible Value Trap.

Key valuation signals for BTCY:

  • Cyclically Adjusted Book per Share: $-1.17
  • GF Value™: $0.37 vs. price of $0.09 (75.7% below fair value)
  • GF Score™: 20/100 with 7 warning signs

No single metric tells the full story. See the BTCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biotricity Business Description

Address 203 Redwood Shores Parkway, Suite 600, Redwood City, CA, USA, 94065
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health.
20GF Score

Get the complete analysis for BTCY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price
$0.37
GF Value